We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.85B
AUM Growth
+$319M
Cap. Flow
-$251M
Cap. Flow %
-3.66%
Top 10 Hldgs %
11.1%
Holding
344
New
23
Increased
80
Reduced
183
Closed
14

Sector Composition

Rank Sector Weight
1 Financials 17.3%
2 Industrials 14.96%
3 Technology 14.41%
4 Consumer Discretionary 11.28%
5 Healthcare 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWC
51
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$47.8M 0.7%
352,591
-11,045
-3% -$1.37M
COLM icon
52
Columbia Sportswear
COLM
$3.04B
$47.1M 0.69%
1,196,850
-67,030
-5% -$2.26M
COP icon
53
ConocoPhillips
COP
$147B
$47M 0.69%
665,852
-21,808
-3% -$1.57M
FELE icon
54
Franklin Electric
FELE
$4.63B
$46.8M 0.68%
1,047,559
-66,220
-6% -$2.7M
XRAY icon
55
Dentsply Sirona
XRAY
$2.68B
$46.5M 0.68%
959,269
+46,316
+5% +$2.17M
TEN
56
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$45.7M 0.67%
807,664
+120,488
+18% +$6.56M
CL icon
57
Colgate-Palmolive
CL
$73.1B
$45.4M 0.66%
695,839
+243
+0% +$15.6K
SYNT
58
DELISTED
Syntel Inc
SYNT
$45.3M 0.66%
996,470
+9,126
+0.9% +$395K
HIBB
59
DELISTED
Hibbett, Inc. Common Stock
HIBB
$45.3M 0.66%
674,421
+60,716
+10% +$3.7M
VSI
60
DELISTED
Vitamin Shoppe Inc.
VSI
$44.9M 0.66%
863,551
-56,077
-6% -$2.77M
DFT
61
DELISTED
DuPont Fabros Technology Inc.
DFT
$42.8M 0.62%
1,731,732
-127,715
-7% -$3.11M
IPCM
62
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$41.4M 0.6%
697,500
-42,197
-6% -$2.39M
EMC
63
DELISTED
EMC CORPORATION
EMC
$40.3M 0.59%
1,603,034
-97,640
-6% -$2.37M
HUBG icon
64
HUB Group
HUBG
$2.85B
$40.3M 0.59%
2,018,698
-122,546
-6% -$2.29M
PNC icon
65
PNC Financial Services
PNC
$99.7B
$40M 0.58%
515,253
+3,495
+0.7% +$262K
FET icon
66
Forum Energy Technologies
FET
$708M
$39.6M 0.58%
70,033
-2,921
-4% -$1.65M
NJR icon
67
New Jersey Resources
NJR
$5.84B
$39.4M 0.57%
1,702,550
-112,686
-6% -$2.54M
RVBD
68
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$38.9M 0.57%
2,153,832
-120,147
-5% -$1.95M
CNS icon
69
Cohen & Steers
CNS
$4.23B
$38.8M 0.57%
967,347
-64,766
-6% -$2.49M
CMC icon
70
Commercial Metals
CMC
$7.6B
$38.7M 0.57%
1,905,897
-126,757
-6% -$2.36M
GOOG icon
71
Alphabet (Google) Class C
GOOG
$4.36T
$38.4M 0.56%
1,377,303
+43,442
+3% +$1.1M
STT icon
72
State Street
STT
$50.6B
$38.1M 0.56%
519,780
-10,875
-2% -$762K
CVX icon
73
Chevron
CVX
$392B
$37.4M 0.55%
299,476
-5,495
-2% -$664K
HAE icon
74
Haemonetics
HAE
$3.89B
$37.3M 0.54%
886,153
+124,367
+16% +$5.12M
KWR icon
75
Quaker Houghton
KWR
$2.76B
$37.1M 0.54%
481,069
-34,420
-7% -$2.65M

Similar funds

Boston Trust Walden's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Trust Walden held 344 positions worth $6.85B, up 4.9% from $6.54B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Boston Trust Walden withdrew a net $251M in Q4 2013, closing 14 positions and reducing 183 holdings. Its most notable exit was THE MENS WAREHOUSE INC, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

Against the trend, Boston Trust Walden opened a new position in Encore Capital Group worth $62.3M.

  • Boston Trust Walden's largest Q4 2013 buy was Encore Capital Group: 1,238,927 shares worth $62.3M.
  • Boston Trust Walden added most to BIOMED REALTY TRUST INC in Q4 2013, an estimated $15.1M increase.
  • Boston Trust Walden's biggest Q4 2013 reduction was Sysco, cutting an estimated $23.4M.
  • Boston Trust Walden fully exited THE MENS WAREHOUSE INC in Q4 2013, selling an estimated $37.2M.
  • Boston Trust Walden's ten largest holdings make up 11% of its $6.85B portfolio in Q4 2013.
  • Boston Trust Walden opened 23 new positions and closed 14 in Q4 2013.
  • Boston Trust Walden's portfolio value rose 4.9% quarter-over-quarter to $6.85B.

Based on Boston Trust Walden's 13F filing for Q4 2013, filed 11 Feb 2014.